Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP).
Fujitani Y, Fujimoto S, Takahashi K, Satoh H, Hirose T, Hiyoshi T, Ai M, Okada Y, Gosho M, Mita T, Watada H. Fujitani Y, et al. Among authors: satoh h. Diabetes Res Clin Pract. 2016 Nov;121:146-156. doi: 10.1016/j.diabres.2016.09.014. Epub 2016 Sep 22. Diabetes Res Clin Pract. 2016. PMID: 27710821 Clinical Trial.
Effects of linagliptin vs. voglibose on daily glucose excursions during continuous glucose monitoring of Japanese type 2 diabetes patients (L-CGM): A randomized, open-label, two-arm, parallel comparative trial.
Satoh H, Ohira T, Moriya C, Inoue I, Kuribayashi S, Seino H, Hirai H, Hiyoshi T, Watada H; L-CGM Study Group. Satoh H, et al. Diabetes Metab. 2017 Dec;43(6):550-553. doi: 10.1016/j.diabet.2017.07.010. Epub 2017 Sep 22. Diabetes Metab. 2017. PMID: 28947255 Clinical Trial. No abstract available.
Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.
Kurozumi A, Okada Y, Satoh H, Inoue I, Chimori H, Akita E, Shiraiwa T, Fujitani Y, Mita T, Gosho M, Watada H. Kurozumi A, et al. Among authors: satoh h. Endocr J. 2018 Apr 26;65(4):415-425. doi: 10.1507/endocrj.EJ17-0386. Epub 2018 Jan 25. Endocr J. 2018. PMID: 29367471 Free article. Clinical Trial.
Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP study.
Goto H, Mita T, Fujitani Y, Fujimoto S, Takahashi K, Satoh H, Hirose T, Hiyoshi T, Ai M, Okada Y, Nishimura H, Kuroda H, Matsubara T, Gosho M, Ishii H, Watada H. Goto H, et al. Among authors: satoh h. Endocr J. 2018 Jun 27;65(6):657-668. doi: 10.1507/endocrj.EJ18-0088. Epub 2018 Apr 10. Endocr J. 2018. PMID: 29643323 Free article. Clinical Trial.
Both higher fitness level and higher current physical activity level may be required for intramyocellular lipid accumulation in non-athlete men.
Yamasaki N, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Kaga H, Suzuki R, Sugimoto D, Kadowaki S, Sato M, Nakagata T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Satoh H, Kawamori R, Watada H. Yamasaki N, et al. Among authors: satoh h. Sci Rep. 2020 Mar 5;10(1):4102. doi: 10.1038/s41598-020-61080-5. Sci Rep. 2020. PMID: 32139784 Free PMC article.
Effect of real-life insulin pump with predictive low-glucose management use for 3 months: Analysis of the patients treated in a Japanese center.
Tsunemi A, Sato J, Kurita M, Wakabayashi Y, Waseda N, Koshibu M, Shinohara M, Ozaki A, Nakamura H, Hirano N, Ikeda F, Satoh H, Watada H. Tsunemi A, et al. Among authors: satoh h. J Diabetes Investig. 2020 Nov;11(6):1564-1569. doi: 10.1111/jdi.13288. Epub 2020 Jun 10. J Diabetes Investig. 2020. PMID: 32374513 Free PMC article.
2,727 results